Episode 36: IRS Warnings, FDA's Approval of Wegovy, and More

On this episode of Ask Michelle, Michelle is joined by special guest KC Rippstein, Compliance Practice Lead at IMA. They provided updates on the San Francisco HCSO Annual Reporting Form, the FDA's approval of Wegovy for cardiovascular disease prevention, and IRS Warnings regarding Employee Retention Credits (ERC) and FICA wellness savings programs.

 

Michelle and KC answered questions regarding the pretax indemnity plan in regard to critical illness and whether C-Corp Shareholders can participate in an HRA/FSA.

 

Curious about a compliance issue? Submit your questions to [e-mail] and Michelle will answer them on the next episode. 

What is Cammayo's Compliance Talk?

Join us for Cammayo’s Compliance Talk: Ask Michelle, a monthly series focused on employee benefits that tackles the latest developments, questions, and conversations that organizations are navigating.

Hear Michelle Cammayo, IMA's in-house compliance expert and thought leader, and her featured guests, answer your submitted compliance questions and share crucial information that organizations need to know.

Send your questions to be answered to [e-mail]